School of Pharmacy, Fudan University, Pudong, Shanghai, China. In 2024, the China National Medical Products Administration (NMPA) approved a total of 228 new drug applications (NDAs), including ...

InspireMD, Inc. has partnered with NAMSA to conduct the CGUARDIANS II pivotal study, evaluating the safety and effectiveness of the CGuard Prime carotid stent system in Transcarotid Artery ...

Mangaluru: An expert committee constituted to examine the Kulai fishing harbour works has suggested the New Mangaluru Port Authority (NMPA) continue with the works and ensure that the quality and ...

Based on the results of the FLAMES study, the National Medicines Products Administration (NMPA) has approved the new drug application for Senaparib. The Wee1 inhibitor IMP7068 and the ATR ...

IceCure Medical has submitted a regulatory filing to China's National Medical Products Administration (NMPA) seeking the approval of its ProSense cryoablation system, which is designed for ...

The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for use ...